Study Comparing NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
This study is comparing three ways to repair peripheral nerve injuries (damage to nerves outside the brain and spinal cord): the NeuroSpan Bridge, the NeuraGen Nerve Guide, and a Nerve Autograft. The NeuroSpan Bridge and NeuraGen Nerve Guide are devices designed to help nerves regrow across a gap. A Nerve Autograft uses a piece of your own nerve to fix the damaged area. Researchers want to see how well these methods help nerves heal and if they cause any problems. They will measure nerve function (static two-point discrimination, or s2PD) and look for complications like infections or pain after 12 months. You might be able to join if you are 18-80 years old with an arm or leg nerve injury between 0.5 and 3.0 cm long. The study is currently unclear on its recruitment status and plans to enroll 80 people.
- Study design
- This is a randomized study where neither you nor the evaluators will know which treatment you receive. It plans to enroll 80 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after their treatment procedure to assess both efficacy and safety.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
At a glance
Conditions
NCT06529835
Where you'd take part
This study runs at 8 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Medstar Union Memorial Hospital- The Curtis National Hand Center
Baltimore, Marylandstudy coordinator listed
Recruiting
NYU Langone Orthopedic Center
New York, New Yorkstudy coordinator listed
Recruiting
OSU Wexner Medical Center
Columbus, Ohiostudy coordinator listed
Recruiting
The San Antonio Orthopaedic Group (TSAOG Orthopaedics)
San Antonio, Texasstudy coordinator listed
Recruiting
UC San Diego Health
San Diego, Californiastudy coordinator listed
Recruiting
UCSF Orthopedic Institute
San Francisco, Californiastudy coordinator listed
Recruiting
University of Pennsylvania- Penn Presbyterian Medical Center
Philadelphia, Pennsylvaniastudy coordinator listed
Recruiting
UT Health Houston
Houston, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Efficacy- Static two-point discrimination (s2PD) measured at 12 months.12 months
This endpoint will examine the change in Static two-point discrimination (s2PD) measured at 12 months.
- Safety- Complications and adverse events including infections, inflammation, tissue rejections, neuroma formation, chronic pain, and device malfunctions occurring between the treatment procedure and the 12-month follow-up visit.12 months
This endpoint will examine complications and adverse events including infections, inflammation, tissue rejections, neuroma formation, chronic pain, and device malfunctions occurring between the treatment procedure and the 12-month follow-up visit.